241 related articles for article (PubMed ID: 20009155)
21. Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy?
Franz M; Regele H; Schmaldienst S; Stummvoll HK; Hörl WH; Pohanka E
Transplantation; 1998 Nov; 66(9):1258-62. PubMed ID: 9825827
[TBL] [Abstract][Full Text] [Related]
22. Tacrolimus Concentration/Dose Ratio is Associated with Renal Function After Liver Transplantation.
Thölking G; Siats L; Fortmann C; Koch R; Hüsing A; Cicinnati VR; Gerth HU; Wolters HH; Anthoni C; Pavenstädt H; Suwelack B; Schmidt HH; Kabar I
Ann Transplant; 2016 Mar; 21():167-79. PubMed ID: 27003330
[TBL] [Abstract][Full Text] [Related]
23. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence.
Issa N; Kukla A; Ibrahim HN
Am J Nephrol; 2013; 37(6):602-12. PubMed ID: 23796509
[TBL] [Abstract][Full Text] [Related]
24. De novo tacrolimus- associated hemolytic uremic syndrome after renal transplantation - case report.
Neto P; Lopes K; Macário F; Alves R; Mota A; Campos M
Nefrologia; 2013 Jan; 33(1):152-4. PubMed ID: 23364650
[No Abstract] [Full Text] [Related]
25. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
26. Conversion of renal transplant recipients from cyclosporin (neoral) to tacrolimus (prograf) for haemolytic uraemic syndrome.
Morris-Stiff G; Talbot D; Balaji V; Baboolal K; Callanan K; Hails J; Moore R; Manas D; Lord R; Jurewicz WA
Transpl Int; 1998; 11 Suppl 1():S98-9. PubMed ID: 9664954
[TBL] [Abstract][Full Text] [Related]
27. Fulminant recurrence of atypical hemolytic uremic syndrome during a calcineurin inhibitor-free immunosuppression regimen.
Florman S; Benchimol C; Lieberman K; Burrows L; Bromberg JS
Pediatr Transplant; 2002 Aug; 6(4):352-5. PubMed ID: 12234280
[TBL] [Abstract][Full Text] [Related]
28. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.
Fairbanks KD; Eustace JA; Fine D; Thuluvath PJ
Liver Transpl; 2003 Oct; 9(10):1079-85. PubMed ID: 14526403
[TBL] [Abstract][Full Text] [Related]
29. Tacrolimus (FK 506)-induced hemolytic uremic syndrome after heart transplantation.
Walder B; Ricou B; Suter PM
J Heart Lung Transplant; 1998 Oct; 17(10):1004-6. PubMed ID: 9811409
[TBL] [Abstract][Full Text] [Related]
30. Impact of the conversion of the immunosuppressive regimen from prograf to advagraf or to sirolimus in long-term stable liver transplant recipients: indications, safety, and outcome.
Perrakis A; Schwarz K; Yedibela S; Croner RS; Hohenberger W; Müller V
Transplant Proc; 2011 Dec; 43(10):3702-7. PubMed ID: 22172830
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of hemolytic uremic syndrome after liver-kidney transplantation.
Gatti S; Arru M; Reggiani P; Como G; Rossi F; Fassati LR; Ponticelli C
J Nephrol; 2003; 16(4):586-90. PubMed ID: 14696763
[TBL] [Abstract][Full Text] [Related]
32. Successful use of cyclosporine in a lung transplant recipient with tacrolimus-associated hemolytic uremic syndrome.
Myers JN; Shabshab SF; Burton NA; Nathan SD
J Heart Lung Transplant; 1999 Oct; 18(10):1024-6. PubMed ID: 10561115
[TBL] [Abstract][Full Text] [Related]
33. Dangerous drug interactions leading to hemolytic uremic syndrome following lung transplantation.
Parissis H; Gould K; Dark J
J Cardiothorac Surg; 2010 Sep; 5():70. PubMed ID: 20813025
[TBL] [Abstract][Full Text] [Related]
34. Early withdrawal of calcineurin inhibitor from a sirolimus-based immunosuppression stabilizes fibrosis and the transforming growth factor-β signalling pathway in kidney transplant.
Rivelli RF; Gonçalves RT; Leite M; Santos MA; Delgado AG; Cardoso LR; Takiya CM
Nephrology (Carlton); 2015 Mar; 20(3):168-76. PubMed ID: 25404086
[TBL] [Abstract][Full Text] [Related]
35. Tacrolimus-induced HUS: an unusual cause of acute renal failure in nephrotic syndrome.
Pandirikkal VB; Jain M; Gulati S
Pediatr Nephrol; 2007 Feb; 22(2):298-300. PubMed ID: 17123120
[TBL] [Abstract][Full Text] [Related]
36. Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation.
Batista F; Auyanet I; Torregrosa JV; Oppenheimer F
Transplant Proc; 2012 Nov; 44(9):2582-4. PubMed ID: 23146461
[TBL] [Abstract][Full Text] [Related]
37. Rescue treatment for cyclosporine-associated hemolytic-uremic syndrome with intravenous immunoglobulin.
Wen YK; Chen ML
Clin Nephrol; 2006 Jul; 66(1):58-62. PubMed ID: 16878437
[TBL] [Abstract][Full Text] [Related]
38. Anti-CD25 monoclonal antibody replacement therapy for chronic kidney disease in liver transplant recipients.
Walsh C; Barkun J; Tchervenkov J; Deschenes M; Ghali P; Wong P; Chaudhury P; Paraskevas S; Metrakos P; Cantarovich M
Transplantation; 2013 Feb; 95(3):495-500. PubMed ID: 23296149
[TBL] [Abstract][Full Text] [Related]
39. Sirolimus as primary immunosuppressant for calcineurin inhibitor-related renal insufficiency after liver transplantation.
Yang YJ; Li LX; He Q; Fan H; Jin ZK; Lang R; Kou JT; Li P; Xie DH; Chen DZ
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):376-8. PubMed ID: 17690032
[TBL] [Abstract][Full Text] [Related]
40. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
